Cécile Toly-Ndour

Suggest Changes
Learn More
Accumulation of amyloid-β peptide (Aβ) is considered the triggering factor of pathogenic lesions in Alzheimer's disease (AD), and vaccines targeting Aβ are promising therapeutic options. However, the(More)
  • 1